Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
ORTHOPEDIATRICS CORP (KIDS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/16/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
05/01/2023 8-K Quarterly results
Docs: "OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance"
05/01/2023 8-K Director compensation was amended/approved
Docs: "LIST OF EXHIBITS AND SCHEDULES Exhibits to Membership Interest Purchase Agreement Exhibit A – Stock Power Exhibit B – Membership Interest Assignment Agreement Exhibit C – Sellers’ Release Exhibit D – Form of Resignation Exhibit E – Unger Employment Agreement Schedules to Membership Interest Purchase Agreement Purchaser’ s Schedules Schedule 1.6 Resigning Managers/Officers Schedule 4.3 Purchaser Required Consents Schedule 6.7 Purchase Price Allocation Methodology Seller’ s Schedules Schedule 2.1 Membership Interest Schedule 2.4 Outstanding Options/Payments based on profitability Schedule 2.7 Accrued Liabilities Schedule 2.9 Compliance with Laws; Permits Schedule 2.10 Litigation Schedule 2.12 Tax Exceptions Schedule 2.14 Intellectual Property Schedule 2.15 Material Contracts Schedule 2.16 In...",
"OrthoPediatrics Corp. Non-Employee Director Compensation Policy, effective January 1, 2023"
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 3"
03/01/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
Docs: "OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A BROWN ADVISORY INC reports a 6.9% stake in OrthoPediatrics Corp.
02/08/2023 SC 13G/A RIVERBRIDGE PARTNERS LLC reports a 4.6% stake in OrthoPediatrics Corp
02/03/2023 5 Pelizzon David R (10% Owner) has filed a Form 5 on ORTHOPEDIATRICS CORP
01/10/2023 5 Bailey David R (President and CEO) has filed a Form 5 on ORTHOPEDIATRICS CORP
01/10/2023 5 Throdahl Mark C (Director) has filed a Form 5 on ORTHOPEDIATRICS CORP
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure  Interactive Data
Docs: "OrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter",
"02 03 04 05 42 0 2 2"
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
09/22/2022 SC 13D/A Squadron Capital LLC reports a 30.3% stake in OrthoPediatrics Corp.
08/17/2022 SC 13D/A Squadron Capital LLC reports a 30.3% stake in OrthoPediatrics Corp.
08/12/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/11/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and among OrthoPediatrics Corp. and Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated, acting as representatives of the several Underwriters named therein",
"Form of Pre-Funded Common Stock Purchase Warrant",
"Opinion of Dentons Bingham Greenebaum LLP",
"OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants",
"OrthoPediatrics Corp. Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants"
08/10/2022 S-3MEF Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
08/10/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "02 03 04 05 42 0 2 2"
08/03/2022 8-K Quarterly results
Docs: "OrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance"
06/15/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy